{"id":701278,"date":"2026-06-28T23:29:49","date_gmt":"2026-06-29T03:29:49","guid":{"rendered":"https:\/\/goldtadise.com\/?p=701278"},"modified":"2026-06-28T23:29:49","modified_gmt":"2026-06-29T03:29:49","slug":"60-cholesterol-lowering-drug-trials-323950-people-statins-pcsk9-inhibitors-ezetimibe-every-drug-class-every-dose","status":"publish","type":"post","link":"https:\/\/goldtadise.com\/?p=701278","title":{"rendered":"60 cholesterol-lowering drug trials. 323,950 people. Statins. PCSK9 inhibitors. Ezetimibe. Every drug class. Every dose."},"content":{"rendered":"<h4>Mortality is the only endpoint that matters. Not LDL levels. Not cholesterol panels. Not relative risk percentages on a drug label. Did the person live or die.<\/h4>\n<p><a href=\"https:\/\/x.com\/markkaplan20\/status\/2070689792807821792\">https:\/\/x.com\/markkaplan20\/status\/2070689792807821792<\/a><\/p>\n<h3>AND<\/h3>\n<h4 class=\"ejp-article-title\">Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: A Systematic Review and Meta-analysis<\/h4>\n<p><a href=\"https:\/\/journals.lww.com\/cardiovascularpharm\/fulltext\/2023\/01000\/extent_of_low_density_lipoprotein_cholesterol.6.aspx\">https:\/\/journals.lww.com\/cardiovascularpharm\/fulltext\/2023\/01000\/extent_of_low_density_lipoprotein_cholesterol.6.aspx<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>Big Pharma will not like this message!<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mortality is the only endpoint that matters. Not LDL levels. Not cholesterol panels. Not relative risk percentages on a drug label. Did the person live or die. https:\/\/x.com\/markkaplan20\/status\/2070689792807821792 AND Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality &hellip; <a href=\"https:\/\/goldtadise.com\/?p=701278\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2948,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-701278","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/701278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/users\/2948"}],"replies":[{"embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=701278"}],"version-history":[{"count":1,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/701278\/revisions"}],"predecessor-version":[{"id":701279,"href":"https:\/\/goldtadise.com\/index.php?rest_route=\/wp\/v2\/posts\/701278\/revisions\/701279"}],"wp:attachment":[{"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=701278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=701278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goldtadise.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=701278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}